FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

686 letters match. Newest first.

  1. MONQ, LLC

    MONQ sold unapproved inhalation essential oil products with claims to treat opioid addiction and withdrawal, FDA and FTC said.

    High risk
  2. Industrias Cklass S. de R.L. de C.V.

    FDA found Industrias Cklass hand sanitizer labeled 70% ethanol contained 19% ethanol and 48% methanol and was refused U.S. admission.

    High risk
  3. Monarch PCM, LLC

    Monarch PCM, LLC made unapproved skin drugs and broke manufacturing rules, with microbial contamination and weak investigations.

    High risk
  4. Golden Lab LLC

    Golden Lab sold eye and allergy capsules with unapproved drug claims and lacked required supplement manufacturing controls.

    High risk
  5. DLG Naturals, Inc.

    DLG Naturals sold shea butter, seed oils, and Kigelia extract as unapproved new drugs (not FDA-approved) with disease-treatment claims on its website.

    Medium
  6. Hybrid Pharma, LLC

    FDA warned outsourcing facility Hybrid Pharma of Deerfield Beach, Florida, that sterile compounding violations made its drugs adulterated and unapproved.

    High risk
  7. Aire-Master of America, Inc.

    FDA cites Aire-Master of America for CGMP failures and unapproved, misbranded hand sanitizers made at its Missouri plant.

    High risk
  8. CAJ Food Products Inc.

    CAJ Food Products marketed Biotta and Juice Performer juices with disease claims, making them unapproved new drugs, FDA says.

    High risk
  9. Hope Botanicals, LLC

    FDA warned Hope Botanicals that its CBD products for animals and humans are unapproved drugs and its raspberry gummies contain an unsafe food additive.

    High risk
  10. Plantacea, LLC dba Kahm

    FDA warned Plantacea, doing business as Kahm, about unapproved CBD drugs for humans and animals and adulterated CBD gummies.

    High risk
  11. Haniel Concepts, Inc. DBA Free State Oils, LLC

    FDA warned Free State Oils over website claims that its CBD products treat disease, including COVID-19, and are unapproved drugs and adulterated foods.

    High risk
  12. Ayuryoga, Inc.

    FDA warned Ayuryoga/Kottakkal Ayurveda USA that its ayurvedic products are unapproved new drugs promoted with disease-treatment claims online.

    High risk
  13. Santhigram Kerala Ayurvedic Co. of U.S., Inc.

    FDA told Santhigram Kerala Ayurvedic Co. of U.S. that its ayurvedic products are unapproved new drugs sold with disease claims online.

    High risk
  14. Sunny Creek Farm, Inc.

    Sunny Creek Farm sold sprouts from pathogen-positive seed lots and made unapproved disease-treatment claims.

    High risk
  15. Inhousepharmacy.vu

    Vanuatu online pharmacy Inhousepharmacy.vu sold unapproved domperidone to US consumers over the internet.

    High risk
  16. Ironmag Labs

    FDA warned Ironmag Labs that its CBD Gummies and stimulant supplements are adulterated (illegal because unsafe/missing filings) and unapproved new drugs.

    High risk
  17. Delta 8 Hemp

    FDA warned Delta 8 Hemp over unapproved Delta-8 THC drugs and adulterated gummies sold online.

    High risk
  18. ATLRx, Inc.

    FDA warned ATLRx that its CBD and Delta-8 THC products are unapproved drugs with illegal disease claims.

    High risk
  19. Kingdom Harvest

    Kingdom Harvest marketed CBD and Delta-8 THC products with unapproved drug claims and unsafe food and animal drug uses.

    High risk
  20. BioMD Plus LLC

    FDA warned BioMD Plus LLC that its CBD and Delta-8 THC products are unapproved drugs and its Delta-8 gummies contain an unsafe food additive.

    High risk
  21. M Six Labs, Inc.

    FDA warned M Six Labs over unapproved CBD/Delta-8 THC drugs, illegal CBD/Delta-8 foods, and animal drugs sold online.

    High risk
  22. C R Supplements, LLC

    FDA warned C R Supplements that its mineral supplements were sold as unapproved new drugs and made without required quality controls.

    High risk
  23. MYA International, Inc.

    FDA warned MYA International that its supplement and herbal product labels made unapproved drug claims and its dietary supplements violated manufacturing quality and labeling rules.

    High risk
  24. Rena's Organic

    U.S. Food and Drug Administration (FDA) warned Rena's Organic over unapproved CBD drug claims for tinctures, creams, foods, and pet product.

    High risk
  25. Guangzhou Zhongkebaishi Health Industry Co., Ltd.

    Guangzhou Zhongkebaishi's Hand Sanitizer Gel, labeled 75% ethanol, tested at 51% and was refused US import.

    High risk
  26. Clinical Resolution Laboratory Inc.

    FDA warned Clinical Resolution Laboratory in Brea, CA, about CGMP failures and unapproved OTC drugs.

    High risk
  27. Kleenhanz, LLC

    FDA told Kleenhanz its antiseptic towelettes were unapproved drugs because the website and Twitter claimed they fight COVID-19 and other diseases.

    High risk
  28. Elements Brands Inc.

    FDA warned Elements Brands that its eb5 Skin Lightening Cream is an unapproved, misbranded new drug.

    High risk
  29. Ultimark Products

    Ultimark Products sells Porcelana Day Skin Lightening Cream, an unapproved and misbranded hydroquinone skin-bleaching drug, FDA says.

    High risk
  30. SkinPro

    SkinPro sells an unapproved, misbranded hydroquinone skin-bleaching drug without FDA approval.

    High risk
  31. Skin PS Brands

    FDA warns Skin PS Brands that Dark Spot Fix, a hydroquinone skin-lightening drug, is an unapproved and misbranded new drug.

    High risk
  32. Clinical Formula LLC

    FDA warned Clinical Formula LLC that its Clinical Formula Bleaching Lotion is an unapproved and misbranded skin-lightening drug.

    Medium
  33. Neoteric Cosmetics, Incorporated/Scott’s Liquid Gold, Inc.

    FDA warned Neoteric Cosmetics and parent Scott's Liquid Gold that ALPHA Skin Care Dual Action Fade Cream, a hydroquinone skin lightener, is an unapproved and misbranded drug.

    Medium
  34. Dr. Thomas Balshi/Intilight

    FDA warned Dr. Thomas Balshi/Intilight that its hydroquinone skin-lightening cream is an unapproved and misbranded new drug.

    High risk
  35. Skin Authority, L.L.C.

    FDA warns Skin Authority that its skinauthority Hyperpigmentation Treatment is an unapproved and misbranded skin-bleaching drug.

    High risk
  36. AMBI Enterprises LLC

    AMBI sold two unapproved hydroquinone skin-bleaching fade creams with unlawful labeling, FDA says.

    High risk
  37. Genomma Lab USA, Inc.

    Genomma Lab USA sold two hydroquinone skin-lightening creams as unapproved and misbranded new drugs, FDA says.

    High risk
  38. M & M Beauty and Wellness, LLC

    FDA says M & M Beauty and Wellness sells an unapproved, misbranded hydroquinone skin-lightening cream.

    High risk
  39. True Earth Health Products, LLC

    FDA warned True Earth Health Products over Plexaderm Dark Spot Fade Gel, an unapproved, misbranded hydroquinone skin-bleaching drug.

    High risk
  40. www.wellerectile.com

    FDA warned India-based www.wellerectile.com over selling unapproved, improperly labeled drugs online, including hydroxychloroquine claimed to treat COVID-19.

    High risk
  41. Generitech Corporation

    FDA warned Generitech Corporation of Fresno, California over CGMP failures in its topical drug manufacturing and unapproved hydroquinone skin bleaching creams.

    High risk
  42. CofixRx, LLC

    FDA warned CofixRx that its CofixRX Nasal Spray is an unapproved, misbranded drug sold with COVID-19 prevention claims.

    High risk
  43. Sensory Cloud, Inc

    FDA and FTC warn Sensory Cloud that its FEND nasal mister is an unapproved, misbranded drug sold with COVID-19 prevention and treatment claims.

    High risk
  44. NDAL Mfg Inc.

    NDAL Mfg's honey nasal sprays had manufacturing-rule violations, microbial contamination, and lacked FDA approval as new drugs.

    High risk
  45. Honey Feast, Inc.

    Honey Feast, Inc. sold honey products online with disease-treatment claims, making them unapproved new drugs and misbranded.

    Low
  46. CBD Social

    FDA and FTC warn CBD Social over website claims that CBD products prevent or treat COVID-19.

    High risk
  47. Functional Remedies, LLC D/B/A Synchronicity Hemp Oil

    FDA and FTC told a Louisville, Colorado hemp and CBD seller that its website claims the products treat or prevent COVID-19, making them unapproved and misbranded drugs.

    High risk
  48. Cureganics

    Cureganics sold CBD products with website claims they prevent or treat COVID-19, making them unapproved and misbranded drugs.

    High risk
  49. Nature's Highway

    FDA and FTC warned CBD seller Nature's Highway for selling unapproved drugs claimed to treat or prevent COVID-19.

    High risk
  50. UPSY LLC

    FDA and FTC warned UPSY LLC that its website sells CBD products claimed to treat or prevent COVID-19 as unapproved, misbranded drugs.

    High risk